Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
BAG proteins compete with Hip for binding to the Hsc70/Hsp70 ATPase domain and promote substrate release. Additionally we are shipping BAG2 Proteins (13) and many more products for this protein.
Showing 10 out of 89 products:
Human Polyclonal BAG2 Primary Antibody for ICC, IF - ABIN4282947
Dai, Qian, Li, McDonough, Borchers, Huang, Takayama, Younger, Ren, Cyr, Patterson: Regulation of the cytoplasmic quality control protein degradation pathway by BAG2. in The Journal of biological chemistry 2005
Show all 2 Pubmed References
Human Polyclonal BAG2 Primary Antibody for IHC, IHC (p) - ABIN4282948
Gupta, Tahrir, Knezevic, White, Gordon, Cheung, Khalili, Feldman: GRP78 Interacting Partner Bag5 Responds to ER Stress and Protects Cardiomyocytes From ER Stress-Induced Apoptosis. in Journal of cellular biochemistry 2016
Cow (Bovine) Polyclonal BAG2 Primary Antibody for IHC, WB - ABIN2775278
Arndt, Daniel, Nastainczyk, Alberti, Höhfeld: BAG-2 acts as an inhibitor of the chaperone-associated ubiquitin ligase CHIP. in Molecular biology of the cell 2005
Show all 2 Pubmed References
A comprehensive review of the structure, functions, and protein interactions of BAG2
Data show that BAG2 Inhibits CHIP-Mediated HSP72 (show HSPA1A Antibodies) ubiquitination in aged cells.
repression of BAG2 expression or BAG2 activity by cold-sensitive pathways, as modeled in undifferentiated and differentiated cells, respectively, may be a causal factor in the accumulation of cytotoxic hyperphosphorylated tau protein.
NF-kappaB (show NFKB1 Antibodies)-mediated modulation of BAG2 expression regulates the shift between the neurotrophic and neurotoxic effects of Abeta1-42.
Thus, BAG2 promotes mutant p53 (show TP53 Antibodies) accumulation and gain-of-function in tumor growth, metastasis and chemoresistance.
This study showed that BAG2 (Bcl-2 (show BCL2 Antibodies) associated athanogene family protein 2) and BAG5 (show BAG5 Antibodies) (Bcl-2 (show BCL2 Antibodies)-associated athanogene family protein 5 (show CAPS Antibodies)) stabilise pathogenic ataxin3-80Q by inhibiting its ubiquitination
we measured the binding of human Hsp72 (HSPA1A (show HSPA1A Antibodies)) to BAG1 (show BAG1 Antibodies), BAG2, BAG3 (show BAG3 Antibodies), and the unrelated NEF Hsp105 (show HSPH1 Antibodies). These studies revealed a clear hierarchy of affinities: BAG3 (show BAG3 Antibodies) > BAG1 (show BAG1 Antibodies) > Hsp105 (show HSPH1 Antibodies) >> BAG2.
this data correlate BAG2 to PINK1 (show PINK1 Antibodies) for the first time, strengthening the important role of BAG2 in Parkinson disease -related neurodegeneration.
BAG2 was directly phosphorylated at serine 20 in vitro by MAPKAPK2 (show MAPKAPK2 Antibodies) and MAPKAP2 is also required for phosphorylation of BAG2 in vivo.
BAG2 binds to the carboxyl terminus of Hsp70-interacting protein (CHIP) and provides a cochaperone-dependent regulatory mechanism for preventing unregulated ubiquitylation of misfolded proteins by CHIP
findings support the notion that BAG2 is an upstream regulator of the PINK1 (show PINK1 Antibodies)/PARKIN (show PARK2 Antibodies) signaling pathway.
Native Bag2-NTD crystals diffracted to 2.27 A resolution and belonged to space group P2(1)2(1)2(1), with unit-cell parameters a = 75.5, b = 84.7, c = 114.1 A
Free and Hsc70 (show HSPA8 Antibodies)-bound crystal structures of Bag2-BNB show its dimeric structure, in which a flanking linker helix and loop bind to Hsc70 (show HSPA8 Antibodies) to promote nucleotide exchange.
BAG proteins compete with Hip for binding to the Hsc70/Hsp70 ATPase domain and promote substrate release. All the BAG proteins have an approximately 45-amino acid BAG domain near the C terminus but differ markedly in their N-terminal regions. The predicted BAG2 protein contains 211 amino acids. The BAG domains of BAG1, BAG2, and BAG3 interact specifically with the Hsc70 ATPase domain in vitro and in mammalian cells. All 3 proteins bind with high affinity to the ATPase domain of Hsc70 and inhibit its chaperone activity in a Hip-repressible manner.
BCL2-associated athanogene 2
, BAG family molecular chaperone regulator 2
, putative BCL2-associated athanogene 2
, BAG-family molecular chaperone regulator-2
, bcl-2-associated athanogene 2
, dJ417I1.2 (BAG-family molecular chaperone regulator 2)